Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Net Margin: 2020-2025

Historic Net Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 16.02%.

  • Cellebrite DI's Net Margin rose 20982.00% to 16.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.74%, marking a year-over-year increase of 9903.00%. This contributed to the annual value of -70.54% for FY2024, which is 4559.00% down from last year.
  • Cellebrite DI's Net Margin amounted to 16.02% in Q3 2025, which was down 6.83% from 17.19% recorded in Q2 2025.
  • Cellebrite DI's 5-year Net Margin high stood at 88.86% for Q1 2022, and its period low was -193.80% during Q3 2024.
  • Its 3-year average for Net Margin is -30.77%, with a median of -15.75% in 2023.
  • In the last 5 years, Cellebrite DI's Net Margin tumbled by 20,152bps in 2024 and then skyrocketed by 20,982bps in 2025.
  • Cellebrite DI's Net Margin (Quarterly) stood at 76.38% in 2021, then tumbled by 6,682bps to 9.56% in 2022, then plummeted by 2,531bps to -15.75% in 2023, then spiked by 3,342bps to 17.67% in 2024, then skyrocketed by 20,982bps to 16.02% in 2025.
  • Its Net Margin was 16.02% in Q3 2025, compared to 17.19% in Q2 2025 and 16.18% in Q1 2025.